Mesothelioma is a form a cancer with a notably poor prognosis given mesothelioma survival rates are extremely low; mesothelioma life expectancy following diagnosis ranges between eight and fourteen months. The primary reason for poor mesothelioma survival rates is the lengthy mesothelioma latency period as well as the fact that early mesothelioma symptoms are indicative of numerous other respiratory diseases as well, often delaying a correct diagnosis. While Stage 1 or stage 2 mesothelioma is often potentially curable, Stage 3 and stage 4 mesothelioma is not; such patients are often relegated to palliative treatments to relieve symptoms and restore quality of life. Early detection is the key to increasing mesothelioma survival rates.
Mesothelioma prognosis is officially determined by a standard measure known as the relative five-year survival rate. This number indicates how many patients are still alive five years after being diagnosed with the disease. Currently, the relative five-year survival rate for mesothelioma is about 10 percent, a number that is significantly higher than it was a few decades ago. The one-year survival rate has also improved throughout the last 20 years or so and now sits at approximately 40 percent. Nevertheless, overall mesothelioma survival rates remain poor.
Mesothelioma survival rate varies from patient to patient, with some patients being able to far exceed initial prognosis at diagnosis